Mariko Hojo

Author PubWeight™ 16.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metabolic syndrome and gastrointestinal diseases. J Gastroenterol 2007 1.12
2 Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up. Scand J Gastroenterol 2005 0.99
3 Increased esophageal sensitivity to acid and saline in patients with nonerosive gastro-esophageal reflux disease. J Clin Gastroenterol 2006 0.96
4 Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J Gastroenterol 2005 0.94
5 Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis. World J Gastroenterol 2009 0.90
6 A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan. Scand J Gastroenterol 2014 0.90
7 Presence of vertebral fractures is highly associated with hiatal hernia and reflux esophagitis in Japanese elderly people. Intern Med 2008 0.90
8 Use of selective serotonin reuptake inhibitors and upper gastrointestinal disease. Intern Med 2011 0.87
9 Gastrointestinal hemorrhage as the first manifestation of metastatic extragonadal choriocarcinoma. Intern Med 2009 0.85
10 Clinical feature of asymptomatic reflux esophagitis in patients who underwent upper gastrointestinal endoscopy. J Gastroenterol Hepatol 2012 0.82
11 Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan. J Gastroenterol Hepatol 2006 0.81
12 Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen. J Gastroenterol 2004 0.81
13 Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia. J Gastroenterol Hepatol 2010 0.81
14 Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Digestion 2003 0.79
15 Efficacy of Lansap combination therapy for eradication of H. pylori. Helicobacter 2007 0.78
16 [GERD and tight junction proteins of the esophageal mucosa]. Nihon Rinsho 2004 0.78
17 Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'. Digestion 2013 0.76
18 Current perspectives on reflux laryngitis. Clin J Gastroenterol 2014 0.76
19 Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population. Helicobacter 2002 0.76
20 Diaphragm-like stricture in the duodenum in a patient with systemic sclerosis: unrelated to non-steroidal anti-inflammatory drug use. Intern Med 2007 0.75
21 Pretreatment prediction of symptom response to proton pump inhibitor therapy. J Gastroenterol Hepatol 2015 0.75
22 Establishment of a reflux esophago-laryngitis model in rats. Dig Dis Sci 2010 0.75
23 [Q & A. Case of metastatic cancer discovered at the detection of melena]. Nihon Shokakibyo Gakkai Zasshi 2012 0.75
24 [Second-line therapy for Helicobacter pylori]. Nihon Rinsho 2013 0.75